KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to 7.78%.

  • Teladoc Health's EBITDA Margin fell 28700.0% to 7.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.74%, marking a year-over-year increase of 289900.0%. This contributed to the annual value of 39.02% for FY2024, which is 307700.0% down from last year.
  • As of Q3 2025, Teladoc Health's EBITDA Margin stood at 7.78%, which was down 28700.0% from 4.88% recorded in Q2 2025.
  • Teladoc Health's EBITDA Margin's 5-year high stood at 2.91% during Q4 2021, with a 5-year trough of 1181.51% in Q1 2022.
  • Its 5-year average for EBITDA Margin is 138.42%, with a median of 12.93% in 2024.
  • As far as peak fluctuations go, Teladoc Health's EBITDA Margin tumbled by -11345300bps in 2022, and later surged by 11707900bps in 2023.
  • Teladoc Health's EBITDA Margin (Quarter) stood at 2.91% in 2021, then tumbled by -20384bps to 596.44% in 2022, then skyrocketed by 99bps to 3.69% in 2023, then plummeted by -110bps to 7.76% in 2024, then dropped by 0bps to 7.78% in 2025.
  • Its EBITDA Margin stands at 7.78% for Q3 2025, versus 4.88% for Q2 2025 and 14.6% for Q1 2025.